{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T22:21:41Z","timestamp":1788042101049,"version":"build-2784847793"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100017521","name":"Esteve Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017521","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs R D"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s40268-024-00469-3","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T10:01:55Z","timestamp":1718359315000},"page":"239-252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy of Co-Crystal of Tramadol-Celecoxib (CTC) in Patients with Acute Moderate-to-Severe Pain: A Pooled Analysis of Data from Two Phase 3 Randomized Clinical Trials"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8703-067X","authenticated-orcid":false,"given":"Richard","family":"Langford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0260-4396","authenticated-orcid":false,"given":"Eugene R.","family":"Viscusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3897-8966","authenticated-orcid":false,"given":"Adelaida","family":"Morte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0238-8638","authenticated-orcid":false,"given":"Jes\u00fas","family":"Cebrecos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1908-9271","authenticated-orcid":false,"given":"Mariano","family":"Sust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2675-4919","authenticated-orcid":false,"given":"Jos\u00e9 Mar\u00eda","family":"Gim\u00e9nez-Arnau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0837-9196","authenticated-orcid":false,"given":"Oscar","family":"de Leon-Casasola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"issue":"7","key":"469_CR1","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/AJP.0b013e3182169036","volume":"27","author":"SA Berben","year":"2011","unstructured":"Berben SA, Schoonhoven L, Meijs TH, van Vugt AB, van Grunsven PM. Prevalence and relief of pain in trauma patients in emergency medical services. Clin J Pain. 2011;27(7):587\u201392. https:\/\/doi.org\/10.1097\/AJP.0b013e3182169036.","journal-title":"Clin J Pain"},{"key":"469_CR2","unstructured":"European Society for Emergency Medicine. Guidelines for the management of acute pain in emergency situations. https:\/\/eusem.org\/images\/EUSEM_EPI_GUIDELINES_MARCH_2020.pdf. Accessed 6 Aug 2021."},{"issue":"3","key":"469_CR3","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3109\/10903121003760218","volume":"14","author":"M Galinski","year":"2010","unstructured":"Galinski M, Ruscev M, Gonzalez G, et al. Prevalence and management of acute pain in prehospital emergency medicine. Prehosp Emerg Care. 2010;14(3):334\u20139. https:\/\/doi.org\/10.3109\/10903121003760218.","journal-title":"Prehosp Emerg Care"},{"issue":"5","key":"469_CR4","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.injury.2007.04.013","volume":"39","author":"SA Berben","year":"2008","unstructured":"Berben SA, Meijs TH, van Dongen RT, et al. Pain prevalence and pain relief in trauma patients in the accident & emergency department. Injury. 2008;39(5):578\u201385. https:\/\/doi.org\/10.1016\/j.injury.2007.04.013.","journal-title":"Injury"},{"issue":"3","key":"469_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1053\/ajem.2002.32643","volume":"20","author":"WH Cordell","year":"2002","unstructured":"Cordell WH, Keene KK, Giles BK, Jones JB, Jones JH, Brizendine EJ. The high prevalence of pain in emergency medical care. Am J Emerg Med. 2002;20(3):165\u20139. https:\/\/doi.org\/10.1053\/ajem.2002.32643.","journal-title":"Am J Emerg Med"},{"issue":"2","key":"469_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/EJA.0b013e3283418fb0","volume":"28","author":"S Gu\u00e9ant","year":"2011","unstructured":"Gu\u00e9ant S, Taleb A, Borel-K\u00fchner J, et al. Quality of pain management in the emergency department: results of a multicentre prospective study. Eur J Anaesthesiol. 2011;28(2):97\u2013105. https:\/\/doi.org\/10.1097\/EJA.0b013e3283418fb0.","journal-title":"Eur J Anaesthesiol"},{"key":"469_CR7","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.2147\/jpr.S137992","volume":"10","author":"P Mura","year":"2017","unstructured":"Mura P, Serra E, Marinangeli F, et al. Prospective study on prevalence, intensity, type, and therapy of acute pain in a second-level urban emergency department. J Pain Res. 2017;10:2781\u20138. https:\/\/doi.org\/10.2147\/jpr.S137992.","journal-title":"J Pain Res"},{"issue":"6","key":"469_CR8","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.jpain.2006.12.005","volume":"8","author":"KH Todd","year":"2007","unstructured":"Todd KH, Ducharme J, Choiniere M, et al. Pain in the emergency department: results of the pain and emergency medicine initiative (PEMI) multicenter study. J Pain. 2007;8(6):460\u20136. https:\/\/doi.org\/10.1016\/j.jpain.2006.12.005.","journal-title":"J Pain"},{"issue":"2","key":"469_CR9","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1213\/01.Ane.0000068822.10113.9e","volume":"97","author":"JL Apfelbaum","year":"2003","unstructured":"Apfelbaum JL, Chen C, Mehta SS, Gan TJ. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg. 2003;97(2):534\u201340. https:\/\/doi.org\/10.1213\/01.Ane.0000068822.10113.9e.","journal-title":"Anesth Analg"},{"key":"469_CR10","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.2147\/JPR.S138850","volume":"10","author":"L Butti","year":"2017","unstructured":"Butti L, Bierti O, Lanfrit R, et al. Evaluation of the effectiveness and efficiency of the triage emergency department nursing protocol for the management of pain. J Pain Res. 2017;10:2479\u201388. https:\/\/doi.org\/10.2147\/JPR.S138850.","journal-title":"J Pain Res"},{"issue":"11","key":"469_CR11","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1185\/03007995.2015.1092122","volume":"31","author":"W Meissner","year":"2015","unstructured":"Meissner W, Coluzzi F, Fletcher D, et al. Improving the management of post-operative acute pain: priorities for change. Curr Med Res Opin. 2015;31(11):2131\u201343. https:\/\/doi.org\/10.1185\/03007995.2015.1092122.","journal-title":"Curr Med Res Opin"},{"key":"469_CR12","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.2147\/jpr.S144066","volume":"10","author":"TJ Gan","year":"2017","unstructured":"Gan TJ. Poorly controlled postoperative pain: prevalence, consequences, and prevention. J Pain Res. 2017;10:2287\u201398. https:\/\/doi.org\/10.2147\/jpr.S144066.","journal-title":"J Pain Res"},{"key":"469_CR13","doi-asserted-by":"crossref","unstructured":"Chou R, Griffin JC, Blazina I, Schwarz E, Atchison C, Mauer K. Systematic review on treatments for acute pain: surveillance report 1: literature update period: August 2020 through October 2021. In: Treatments for Acute Pain: A Systematic Review: Surveillance Reports. Rockville: Agency for Healthcare Research and Quality (US); 2020.","DOI":"10.23970\/AHRQEPCSURVEILLANCE1ACUTEPAIN"},{"issue":"12","key":"469_CR14","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.2165\/11633470-000000000-00000","volume":"35","author":"J Castellsague","year":"2012","unstructured":"Castellsague J, Riera-Guardia N, Calingaert B, et al. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Drug Saf. 2012;35(12):1127\u201346. https:\/\/doi.org\/10.2165\/11633470-000000000-00000.","journal-title":"Drug Saf"},{"issue":"4","key":"469_CR15","doi-asserted-by":"publisher","DOI":"10.5812\/aapm.119156","volume":"11","author":"AN Edinoff","year":"2021","unstructured":"Edinoff AN, Kaplan LA, Khan S, et al. Full opioid agonists and tramadol: pharmacological and clinical considerations. Anesth Pain Med. 2021;11(4): e119156. https:\/\/doi.org\/10.5812\/aapm.119156.","journal-title":"Anesth Pain Med"},{"key":"469_CR16","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3389\/fpsyt.2019.00704","volume":"10","author":"KE Dunn","year":"2019","unstructured":"Dunn KE, Bergeria CL, Huhn AS, Strain EC. A systematic review of laboratory evidence for the abuse potential of tramadol in humans. Front Psychiatry. 2019;10:704. https:\/\/doi.org\/10.3389\/fpsyt.2019.00704.","journal-title":"Front Psychiatry."},{"key":"469_CR17","doi-asserted-by":"publisher","first-page":"117822182093000","DOI":"10.1177\/1178221820930006","volume":"14","author":"SA Reines","year":"2020","unstructured":"Reines SA, Goldmann B, Harnett M, Lu L. Misuse of tramadol in the United States: an analysis of the national survey of drug use and health 2002\u20132017. Subst Abuse. 2020;14:1178221820930006. https:\/\/doi.org\/10.1177\/1178221820930006.","journal-title":"Subst Abuse"},{"issue":"3","key":"469_CR18","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1345\/aph.1H386","volume":"41","author":"GM Oderda","year":"2007","unstructured":"Oderda GM, Said Q, Evans RS, et al. Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay. Ann Pharmacother. 2007;41(3):400\u20136. https:\/\/doi.org\/10.1345\/aph.1H386.","journal-title":"Ann Pharmacother"},{"issue":"9 Suppl","key":"469_CR19","doi-asserted-by":"publisher","first-page":"6s","DOI":"10.1002\/j.1875-9114.2012.01177.x","volume":"32","author":"G Oderda","year":"2012","unstructured":"Oderda G. Challenges in the management of acute postsurgical pain. Pharmacotherapy. 2012;32(9 Suppl):6s\u201311s. https:\/\/doi.org\/10.1002\/j.1875-9114.2012.01177.x.","journal-title":"Pharmacotherapy"},{"issue":"3","key":"469_CR20","first-page":"1056","volume":"299","author":"LA Marsch","year":"2001","unstructured":"Marsch LA, Bickel WK, Badger GJ, et al. Effects of infusion rate of intravenously administered morphine on physiological, psychomotor, and self-reported measures in humans. J Pharmacol Exp Ther. 2001;299(3):1056\u201365.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"469_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s40122-018-0106-9","volume":"7","author":"TJ Gan","year":"2018","unstructured":"Gan TJ, Epstein RS, Leone-Perkins ML, Salimi T, Iqbal SU, Whang PG. Practice patterns and treatment challenges in acute postoperative pain management: a survey of practicing physicians. Pain Ther. 2018;7(2):205\u201316. https:\/\/doi.org\/10.1007\/s40122-018-0106-9.","journal-title":"Pain Ther"},{"issue":"8","key":"469_CR22","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jpain.2009.12.010","volume":"11","author":"RB Raffa","year":"2010","unstructured":"Raffa RB, Pergolizzi JV Jr, Tallarida RJ. The determination and application of fixed-dose analgesic combinations for treating multimodal pain. J Pain. 2010;11(8):701\u20139. https:\/\/doi.org\/10.1016\/j.jpain.2009.12.010.","journal-title":"J Pain"},{"issue":"6","key":"469_CR23","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1080\/03007995.2017.1310092","volume":"33","author":"G Varrassi","year":"2017","unstructured":"Varrassi G, Hanna M, Macheras G, et al. Multimodal analgesia in moderate-to-severe pain: a role for a new fixed combination of dexketoprofen and tramadol. Curr Med Res Opin. 2017;33(6):1165\u201373. https:\/\/doi.org\/10.1080\/03007995.2017.1310092.","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"469_CR24","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1021\/acs.cgd.6b01848","volume":"17","author":"C Almansa","year":"2017","unstructured":"Almansa C, Merc\u00e8 R, Tesson N, Farran J, Tom\u00e0s J, Plata-Salam\u00e1n CR. Co-crystal of tramadol hydrochloride\u2013celecoxib (CTC): a novel API\u2013API co-crystal for the treatment of pain. Cryst Growth Des. 2017;17(4):1884\u201392. https:\/\/doi.org\/10.1021\/acs.cgd.6b01848.","journal-title":"Cryst Growth Des"},{"issue":"13","key":"469_CR25","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2165\/00003088-200443130-00004","volume":"43","author":"S Grond","year":"2004","unstructured":"Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43(13):879\u2013923. https:\/\/doi.org\/10.2165\/00003088-200443130-00004.","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl","key":"469_CR26","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1016\/j.clinthera.2007.12.008","volume":"29","author":"R Cheung","year":"2007","unstructured":"Cheung R, Krishnaswami S, Kowalski K. Analgesic efficacy of celecoxib in postoperative oral surgery pain: a single-dose, two-center, randomized, double-blind, active- and placebo-controlled study. Clin Ther. 2007;29(Suppl):2498\u2013510. https:\/\/doi.org\/10.1016\/j.clinthera.2007.12.008.","journal-title":"Clin Ther"},{"key":"469_CR27","unstructured":"US Food and Drug Administration. Prescribing information, SELGENTIS. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/213426s000lbl.pdf. Accessed 15 Jan 2024."},{"key":"469_CR28","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitos. Velyntra Spanish regulatory approval. https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/89051\/FT_89051.html. Accessed 23 Jan 2024."},{"key":"469_CR29","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.2147\/jpr.S208082","volume":"12","author":"C Almansa","year":"2019","unstructured":"Almansa C, Frampton CS, Vela JM, Whitelock S, Plata-Salam\u00e1n CR. Co-crystals as a new approach to multimodal analgesia and the treatment of pain. J Pain Res. 2019;12:2679\u201389. https:\/\/doi.org\/10.2147\/jpr.S208082.","journal-title":"J Pain Res"},{"issue":"6","key":"469_CR30","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.clinthera.2021.04.002","volume":"43","author":"J Cebrecos","year":"2021","unstructured":"Cebrecos J, Carlson JD, Encina G, et al. Celecoxib-tramadol co-crystal: a randomized 4-way crossover comparative bioavailability study. Clin Ther. 2021;43(6):1051\u201365. https:\/\/doi.org\/10.1016\/j.clinthera.2021.04.002.","journal-title":"Clin Ther"},{"issue":"6","key":"469_CR31","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1021\/acs.cgd.9b00008","volume":"19","author":"A Port","year":"2019","unstructured":"Port A, Almansa C, Enrech R, Bordas M, Plata-Salam\u00e1n CR. Differential solution behavior of the new API\u2013API co-crystal of tramadol\u2013celecoxib (CTC) versus its constituents and their combination. Cryst Growth Des. 2019;19(6):3172\u201382.","journal-title":"Cryst Growth Des"},{"issue":"12","key":"469_CR32","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1111\/bcp.13395","volume":"83","author":"S Videla","year":"2017","unstructured":"Videla S, Lahjou M, Vaqu\u00e9 A, et al. Single-dose pharmacokinetics of co-crystal of tramadol-celecoxib: results of a four-way randomized open-label phase I clinical trial in healthy subjects. Br J Clin Pharmacol. 2017;83(12):2718\u201328. https:\/\/doi.org\/10.1111\/bcp.13395.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"469_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/bcp.13428","volume":"84","author":"S Videla","year":"2018","unstructured":"Videla S, Lahjou M, Vaqu\u00e9 A, et al. Pharmacokinetics of multiple doses of co-crystal of tramadol-celecoxib: findings from a four-way randomized open-label phase I clinical trial. Br J Clin Pharmacol. 2018;84(1):64\u201378. https:\/\/doi.org\/10.1111\/bcp.13428.","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"469_CR34","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1002\/ejp.2021","volume":"26","author":"R Langford","year":"2022","unstructured":"Langford R, Morte A, Sust M, et al. Efficacy and safety of co-crystal of tramadol-celecoxib (CTC) in acute moderate-to-severe pain after abdominal hysterectomy: a randomized, double-blind, phase 3 trial (STARDOM2). Eur J Pain. 2022;26(10):2083\u201396. https:\/\/doi.org\/10.1002\/ejp.2021.","journal-title":"Eur J Pain"},{"issue":"3","key":"469_CR35","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/03007995.2023.2276118","volume":"40","author":"R Langford","year":"2024","unstructured":"Langford R, Margarit C, Morte A, et al. Co-crystal of tramadol-celecoxib (CTC) for acute moderate-to-severe pain. Curr Med Res Opin. 2024;40(3):455\u201368. https:\/\/doi.org\/10.1080\/03007995.2023.2276118.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"469_CR36","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s12325-023-02744-2","volume":"41","author":"R Langford","year":"2024","unstructured":"Langford R, Pogatzki-Zahn EM, Morte A, et al. Co-crystal of tramadol-celecoxib versus tramadol or placebo for acute moderate-to-severe pain after oral surgery: randomized, double-blind, phase 3 trial (STARDOM1). Adv Ther. 2024;41(3):1025\u201345. https:\/\/doi.org\/10.1007\/s12325-023-02744-2.","journal-title":"Adv Ther"},{"issue":"1","key":"469_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/papr.13136","volume":"23","author":"ER Viscusi","year":"2023","unstructured":"Viscusi ER, de Leon-Casasola O, Cebrecos J, et al. Celecoxib-tramadol co-crystal in patients with moderate-to-severe pain following bunionectomy with osteotomy: a phase 3, randomized, double-blind, factorial, active- and placebo-controlled trial. Pain Pract. 2023;23(1):8\u201322. https:\/\/doi.org\/10.1111\/papr.13136.","journal-title":"Pain Pract"},{"issue":"5","key":"469_CR38","doi-asserted-by":"publisher","first-page":"R1046","DOI":"10.1186\/ar1782","volume":"7","author":"RA Moore","year":"2005","unstructured":"Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids. Arthritis Res Ther. 2005;7(5):R1046\u201351. https:\/\/doi.org\/10.1186\/ar1782.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"469_CR39","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/ajp.0000000000000792","volume":"36","author":"M Echeverria-Villalobos","year":"2020","unstructured":"Echeverria-Villalobos M, Stoicea N, Todeschini AB, et al. Enhanced recovery after surgery (ERAS): a perspective review of postoperative pain management under ERAS pathways and its role on opioid crisis in the United States. Clin J Pain. 2020;36(3):219\u201326. https:\/\/doi.org\/10.1097\/ajp.0000000000000792.","journal-title":"Clin J Pain"},{"issue":"6","key":"469_CR40","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.bja.2023.02.037","volume":"130","author":"TJ Adams","year":"2023","unstructured":"Adams TJ, Aljohani DM, Forget P. Perioperative opioids: a narrative review contextualising new avenues to improve prescribing. Br J Anaesth. 2023;130(6):709\u201318. https:\/\/doi.org\/10.1016\/j.bja.2023.02.037.","journal-title":"Br J Anaesth"},{"issue":"2","key":"469_CR41","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jpain.2015.12.008","volume":"17","author":"R Chou","year":"2016","unstructured":"Chou R, Gordon DB, de Leon-Casasola OA, et al. Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists\u2019 committee on regional anesthesia, executive committee, and administrative council. J Pain. 2016;17(2):131\u201357. https:\/\/doi.org\/10.1016\/j.jpain.2015.12.008.","journal-title":"J Pain"},{"issue":"2","key":"469_CR42","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1002\/bjs.11477","volume":"107","author":"C Small","year":"2020","unstructured":"Small C, Laycock H. Acute postoperative pain management. Br J Surg. 2020;107(2):e70\u201380. https:\/\/doi.org\/10.1002\/bjs.11477.","journal-title":"Br J Surg"},{"issue":"3","key":"469_CR43","doi-asserted-by":"publisher","first-page":"203","DOI":"10.5055\/jom.2010.0063","volume":"7","author":"KP Anastassopoulos","year":"2011","unstructured":"Anastassopoulos KP, Chow W, Ackerman SJ, Tapia C, Benson C, Kim MS. Oxycodone-related side effects: impact on degree of bother, adherence, pain relief, satisfaction, and quality of life. J Opioid Manag. 2011;7(3):203\u201315. https:\/\/doi.org\/10.5055\/jom.2010.0063.","journal-title":"J Opioid Manag"},{"issue":"2","key":"469_CR44","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/j.pain.0000000000000375","volume":"157","author":"SA Cooper","year":"2016","unstructured":"Cooper SA, Desjardins PJ, Turk DC, et al. Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendations. Pain. 2016;157(2):288\u2013301. https:\/\/doi.org\/10.1097\/j.pain.0000000000000375.","journal-title":"Pain"},{"key":"469_CR45","unstructured":"European Medicines Agency. Guideline on the clinical development of medicinal products intended for the treatment of pain. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-clinical-development-medicinal-products-intended-treatment-pain-first-version_en.pdf. Accessed 20 Feb 2024."},{"key":"469_CR46","unstructured":"US Food and Drug Administration. Development of non-opioid analgesics for acute pain: guidance for industry. https:\/\/www.fda.gov\/media\/156063\/download. Accessed 2 Feb 2024."},{"issue":"2","key":"469_CR47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s40122-017-0074-5","volume":"6","author":"NK Singla","year":"2017","unstructured":"Singla NK, Meske DS, Desjardins PJ. Exploring the interplay between rescue drugs, data imputation, and study outcomes: conceptual review and qualitative analysis of an acute pain data set. Pain Ther. 2017;6(2):165\u201375. https:\/\/doi.org\/10.1007\/s40122-017-0074-5.","journal-title":"Pain Ther"}],"container-title":["Drugs in R&D"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-024-00469-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40268-024-00469-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-024-00469-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T10:28:29Z","timestamp":1723199309000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40268-024-00469-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["469"],"URL":"https:\/\/doi.org\/10.1007\/s40268-024-00469-3","relation":{},"ISSN":["1174-5886","1179-6901"],"issn-type":[{"value":"1174-5886","type":"print"},{"value":"1179-6901","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"28 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was supported by ESTEVE Pharmaceuticals S.A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"R.L. reports consulting and speaker fees from Avenue Therapeutics, BioQ Pharma, Camarus, Compass, Eli Lilly, Gr\u00fcnenthal GmbH, Gr\u00fcnenthal Ltd, GSK, Heron Therapeutics, MedinCell, Mundipharma, Pfizer, and Sintetica. E.R.V. reports consulting fees from ESTEVE Pharmaceuticals, Heron Therapeutics, Merck, Orion Pharmaceuticals, Salix Pharmaceuticals, and Vertex. A.M., J.C., M.S., and J.M.G.A. are employees of ESTEVE Pharmaceuticals. O.d.L.-C. reports personal fees for advisory board membership from ESTEVE Pharmaceuticals during the conduct of the study, and from ESTEVE Pharmaceuticals, Merck, and Stimgenics-Medtronic outside the submitted work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This was a pooled analysis of two previously reported clinical trials. Both studies were conducted in compliance with the Declaration of Helsinki and Good Clinical Practice guidelines and received ethical approval.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All patients provided written informed consent.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate\/Consent for Publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"ESTEVE Pharmaceuticals S.A. will consider requests for de-identified patient-level data and supporting study documents from qualified external researchers. Approval of requests will be at the discretion of ESTEVE Pharmaceuticals S.A. and will depend on the scientific merit of the proposed research and intended use of the data. If approval is granted, a Data Sharing Agreement must be signed and access to data will be provided only if ESTEVE Pharmaceuticals S.A. has legal authority to provide the data and there are no contradictory requirements relating to regulatory filings or reviews. Proposals should be sent to esteve@esteve.com.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"R.L., E.R.V., A.M., J.C., M.S., and O.d.L.-C. conceived or designed the studies. J.C. contributed to data collection. R.L., E.R.V., A.M., J.C., M.S., J.M.G.A., and O.d.L.-C. contributed to data analysis and\/or interpretation. All authors drafted, edited, and\/or reviewed drafts of the manuscript, and all approved the final version, and agree to be accountable for the accuracy and integrity of the work.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}